The authors assessed the influence of cognitive reserve (CR) on the evolution of cognitive performance over a 1.6-year follow-up period in 35 patients with relapsing-remitting multiple sclerosis. CR protected patients' cognitive performance in those with higher cortical volumes, pointing to a time window of intervention in the earliest phases of the disease. See p. 1728; Editorial, p. 1724 Transglutaminase 6 antibodies in the diagnosis of gluten ataxia
This study looked at the prevalence of transglutaminase 6 (TG6) in gluten-related diseases and controls, as well as the ability of TG6 antibody to identify patients with gluten ataxia in the absence of other gluten-related serologic markers. Antibodies against TG6
were gluten-dependent and may be a specific marker of gluten ataxia. Treatment with statins and ischemic stroke severity: Does the dose matter?
In 969 stroke patients, 23% were taking low to moderate doses of statins and 4.1% took higher doses of statins prior to stroke.
Pretreatment with statins was associated with lower stroke severity, by the NIH Stroke Scale, both at high as well as low to moderate doses. 
